Loading clinical trials...
Loading clinical trials...
Background: \- PIK3CA-related overgrowth spectrum (PROS) is caused by changes in the PIK3CA gene. This gene makes a protein that communicates with other proteins in the body to cause cells to grow. A...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Human Genome Research Institute (NHGRI)
NCT07015203 · Preeclampsia (PE), Fetal Growth Restriction, and more
NCT07471373 · Endometriosis, Infertility, and more
NCT02769975 · Adrenal Insufficiency, Growth Disorder, and more
NCT06662045 · Iron-Deficiency Anemia, Neurobehavioral Manifestations, and more
NCT03283852 · Disorders of Sex Development, Growth Disorders, and more
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions